“…Lyotropic nonlamellar liquid crystalline (LLC) nanoparticles are attracting increasing interest as alternative vehicles to conventional drug carriers (e.g., emulsions, liposomes, and solid lipid nanoparticles) for developing nanomedicines. − LLC nanoparticles are typically produced from biologically relevant amphiphilic lipids (including single unsaturated monoglycerides and their combinations with unsaturated fatty acids) and show a diverse range of internal structural features. − ,− Among this family of nanoparticles, also known as ISAsomes ( Internally Self-Assembled somes ), cubosomes and hexosomes with unique nanostructures are the most investigated vehicles (inverse bicontinuous cubic (Q 2 ) and discontinuous hexagonal (H 2 ) phases, respectively). ,, These nano-self-assemblies can efficiently encapsulate various bioactive compounds (including drugs, peptides, and nucleic acids). ,,− …”